Skip to content

Evaluation of a Psychotherapeutic Intervention Model in Nursing

Short-term Efficacy Evaluation of a Psychotherapeutic Intervention Model in Nursing on Nursing Diagnosis Anxiety: A Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02930473
Enrollment
133
Registered
2016-10-12
Start date
2016-11-30
Completion date
2017-05-31
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

Psychotherapy, Nursing, Nursing Care, Nursing Model, Randomised Controlled Trial

Brief summary

This study aims to evaluate the efficacy of a psychotherapeutic intervention model in nursing on the nursing diagnosis Anxiety. A randomised controlled trial will be carried out to do so.

Detailed description

This study aims to evaluate the efficacy of a psychotherapeutic intervention model in nursing on nursing diagnosis Anxiety (according to International Classification for Nursing Practice (ICNP)/North American Nursing Diagnoses Association (NANDA) standardized nursing language). A randomised controlled trial will be carried out to do so. In a single-blinded nurse-led 6 months controlled trial, conducted at a hospital outpatient setting in Portugal, approximately 60 patients with anxiety will be randomised to the intervention (n=30) or control groups (n=30). The objective is to compare the outcomes associated with treatment-as-usual and the benefits of implementing the psychotherapeutic intervention model in nursing previously developed (5 sessions), which will be evaluated using Nursing Outcomes Classification (NOC) outcomes Anxiety Level and Anxiety Self-Control (Portuguese version).

Interventions

BEHAVIORALNIC Psychotherapeutic Intervention(s) for Anxiety

Patients will be treated by NIC psychotherapeutic intervention(s) for anxiety (e.g. anxiety reduction) plus psychopharmaceuticals prescribed by their psychiatrist.

DRUGPsychopharmaceuticals (any drugs prescribed by the psychiatrist)

Patients will be treated only by psychopharmaceuticals prescribed by their psychiatrist.

Sponsors

Francisco Miguel Correia Sampaio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* 18-64 years old; * Nursing Diagnosis Anxiety (according to ICNP/NANDA standardized nursing language) - assessment using NOC outcome Anxiety Level (Portuguese version); * Elementary education (completed).

Exclusion criteria

* Psychiatric diagnosis of dementia or psychotic spectrum disorder; * Being in therapy provided by a psychologist (at the moment of the session 0); * Cognitive impairment (assessment using Mini-Mental State Examination); * Moderate or severe intellectual disability; * Confusional state; * Psychomotor agitation.

Design outcomes

Primary

MeasureTime frame
Change in the Level of Anxiety (NOC outcomes Anxiety Level and Anxiety Self-Control - Portuguese version)At the beginning of the study (Session 0) and one week after session 5 (approximately 6 weeks after the beginning of the study)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026